Feb. 19 at 3:51 PM
$NRSN This update truly moved me.
As someone living with ALS, these numbers are not just statistics — they are breaths, time with my children, another conversation around the Shabbat table, another ordinary morning that suddenly becomes extraordinary.
A 65% reduction in risk of death and a greater than 14-month median survival difference — that represents real, tangible hope. Not naïve hope, but hope grounded in rigorous science and deep commitment.
Thank you to the team at NeuroSense Therapeutics for presenting these findings with both responsibility and determination. For those of us living this reality every day, survival and quality of life are not abstract endpoints — they are everything.
Grateful, and hopeful, as you continue forward.
